Diabetes Linked to Increased Cancer, Cardiovascular Disease

Share this content:
Diabetes is associated with increased mortality from cardiovascular disease, cancer, and noncardiovascular noncancer causes.
Diabetes is associated with increased mortality from cardiovascular disease, cancer, and noncardiovascular noncancer causes.

(HealthDay News) -- Diabetes is associated with increased mortality from cardiovascular disease, cancer, and noncardiovascular noncancer causes, according to a study published in Diabetes Care.

Jose Miguel Baena-Díez, from the Hospital del Mar Research Institute in Barcelona, Spain, and colleagues used the pooled analysis of individual data from 12 Spanish cohorts with 10 years of follow-up to examine the correlation between diabetes and cause-specific death.

Data were included for 55,292 individuals aged 35 to 79 years who had no previous history of cardiovascular diseases. The hazard ratios were assessed with and without competing risks: proportional subdistribution hazard (PSH) and cause-specific hazard (CSH), respectively.

The researchers found that 15.6 percent of participants had diabetes and that overall mortality was 9.1 percent. Diabetes increased mortality risk for cardiovascular death: CSH, 2.03 and PSH, 1.99 in men and CSH, 2.28 and PSH, 2.23 in women; cancer death: CSH, 1.37 and PSH, 1.35 for men and CSH, 1.68 and PSH, 1.66 in women; and noncardiovascular noncancer death: CSH, 1.53 and PSH, 1.5 in men and CSH, 1.89 and PSH, 1.84 in women. Individuals with diabetes had higher cumulative mortality function in all instances.

RELATED: Age and Diabetes Linked With Neuropathy for Patients Undergoing Chemotherapy

"Diabetes is associated with premature death from cardiovascular disease, cancer, and noncardiovascular noncancer causes," the authors write. "The use of CSH and PSH provides a comprehensive view of mortality dynamics in a population with diabetes."

Reference

  1. Baena-Díez JM, Peñafiel J, Subirana I, et al. Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis. Diabetes Care. 2016 Aug. dx.doi.org/10.2337/dc16-0614.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters